trial

CBT-I to Improve Functional Outcomes in Veterans With Psychosis

NCTId NCT04646200
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Active Not Recruiting
Enrollment 152 (actual)
Sponsored by VA Office of Research and Development
Primary completion 2026-11-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Active Not Recruiting
Enrollment
152 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2021-11-29
Primary completion
2026-11-30
Eligibility
ALL · 18 Years · 80 Years

Interventions & indications

Drugs
Cognitive Behavioral Therapy-InsomniaHealth and Wellness

Sponsors

VA Office of Research and DevelopmentLead Sponsor

Investigators

1
Elizabeth A. Klingaman, PhDPrincipal Investigator

Sites

2 total
Baltimore, United StatesPhiladelphia, United States

Facts & assertions

4 sourced
Enrollment
152
Phase
NA
Primary Completion Date
2026-11-30
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
Cognitive Behavioral Therapy-Insomnia
drug
Health and Wellness
drug
lead_sponsor
VA Office of Research and Development
company
indication
Sleep Initiation and Maintenance Disorders
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
Elizabeth A. Klingaman, PhD
person